Diabetic Foot Ulcer

·MeSH: Diabetic Foot

8 drugs in development·8 companies·7 clinical trials

Drug Pipeline by Phase

Approved(5)

Drug	Company
altrazeal	ULURU INC. (ULU)
EPIFIX	MiMedx Group Inc (MDXG)
grafix	OSIRIS THERAPEUTICS, INC. (OSIR)
ultramist	SANUWAVE Health Inc. (SNWV)
xcellderma otc	REGENEREX PHARMA, INC. (RGPX)

Phase 2(1)

Drug	Company
cenplacel-l	Celularity Inc. (CELU)

Preclinical(2)

Drug	Company
ipoxyn	NANOMIX CORP (BTHI)
lyoccp	NULIFE SCIENCES, INC. (NULF)

BioSniper tracks 8 drugs in development for Diabetic Foot Ulcer across 8 companies.

There are 7 clinical trials targeting Diabetic Foot Ulcer tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.